Skip to content

HSU secures injunction preventing Asmar and using union resources in legal defence

By API User

The Health Services Union (HSU) has secured a significant legal victory in the Federal Court, obtaining an injunction that prevents Health Workers Union (HWU) Victoria Branch Secretary Diana Asmar and her fellow HWU officials, from using union resources to fund their legal defence. The HSU sought the injunction after learning of the serious allegations contained in the proceedings, initiated by the Fair … Continued

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

By API User

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well tolerated with no serious adverse events, dose-limiting toxicities or clinically relevant findings reported. If approved, this agent could provide an alternative to gadolinium-based contrast agents and address … Continued

MYT Netherlands Parent B.V. (“Mytheresa”) and Richemont sign agreement for Mytheresa to acquire YOOX NET-A-PORTER (“YNAP”) to create leading, global, multi-brand digital luxury group in exchange for a 33% equity stake in Mytheresa

By API User

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR 7 OCTOBER 2024 Richemont will sell YNAP to Mytheresa with a cash position of €555m and no financial debt, subject to customary closing adjustments Mytheresa to issue shares to Richemont representing 33% of Mytheresa’s fully diluted share capital Richemont to provide a €100m revolving credit facility to … Continued

Eastern Health Clinician leading international autoimmune research

By API User

•    Clinical Lead of the Eastern Health Multiple Sclerosis and Neuroimmunology Service, Dr Katherine Buzzard is co-chair of the scientific leadership group (SLG) leading an international database designed to study real-world outcomes in Myasthenia Gravis (MG) aimed at improving the quality of life for those battling the disease. •    MG is a rare … Continued

AUSTRALIA’S TOUGHEST TEAM ENDURANCE EVENT, THE KOKDOA CHALLENGE, COMES TO LAKE MACQUARIE THIS SATURDAY

By API User

The Kokoda Challenge is returning to Lake Macquarie this Saturday 12th October, 2024. Building on last year’s incredible success, where 500 participants raised over $90,000, this year’s challenge promises to be even bigger, with more teams taking on the epic journey through the rugged trails of Olney State Forest and Watagans National Park.   In honour … Continued

Arizona Lithium Secures A$11 Million in Non-Dilutive Cash from Sale of Non-Core Acreage at Prairie Lithium Project

By API User

Perth, Australia – 7 October 2024 | Arizona Lithium Limited (ASX: AZL, AZLO, OTC: AZLAF) (“Arizona Lithium” or “the Company”) is pleased to announce the successful completion of a non-dilutive cash raise of A$11 million through the sale of non-core mineral title and data at its Prairie Lithium Project in Saskatchewan, Canada. The sale to … Continued

Trilliant Shines Spotlight on its Vision for the Future of Energy at Enlit Asia 2024

By API User

Company is Diamond Sponsor; Trilliant thought leaders to take part in valuable presentations, insightful panel discussions and Knowledge Hub sessions KUALA LUMPUR, Malaysia–BUSINESS WIRE– Enlit Asia 2024–For the sixth consecutive year, Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, will participate as Diamond Sponsor at … Continued

Optimism may be increased by taking psychedelic compound psilocybin: study

By API User

Monash University researchers have made a breakthrough in the study of psychedelics to treat disorders including major depression, demonstrating that rats given psilocybin exhibit increased optimism over time. Psilocybin is a psychedelic compound found in magic mushrooms that has shown promise as a novel treatment for depression. However, the information processing mechanisms affected by psilocybin … Continued